Extensive Impairment of Triazolam and Alprazolam Clearance by Short-Term Low-Dose Ritonavir
- 1 August 1999
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 19 (4) , 293-296
- https://doi.org/10.1097/00004714-199908000-00001
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteersBritish Journal of Clinical Pharmacology, 1998
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3AAnnual Review of Pharmacology and Toxicology, 1998
- Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with RitonavirThe Journal of Clinical Pharmacology, 1998
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- Antiretroviral Therapy for HIV InfectionDrugs, 1998
- RitonavirClinical Pharmacokinetics, 1998
- Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavirBritish Journal of Clinical Pharmacology, 1997
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Protease Inhibitors in Patients with HIV DiseaseClinical Pharmacokinetics, 1997
- P-glycoprotein and multidrug resistanceCurrent Opinion in Genetics & Development, 1996